Scorpion sting envenomation in children: factors affecting the outcome

Rajniti Prasad1, Om Prakash Mishra, Nisha Pandey

  • 1Department of Pediatrics, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India. rajnitip@gmail.com

Insights

Scorpion sting envenomation in children is serious. Delayed treatment and symptoms like acidosis, myocarditis, and encephalopathy significantly increase mortality risk.

Area of Science:

  • Pediatric Toxicology
  • Envenomation Management
  • Critical Care Medicine

Background:

  • Scorpion stings pose a significant health risk to children, particularly in endemic regions.
  • Effective management strategies are crucial for improving outcomes in pediatric scorpion sting cases.

Purpose of the Study:

  • To identify factors influencing outcomes in children with scorpion sting envenomation treated with prazosin.
  • To correlate clinical presentation and treatment timing with patient prognosis.

Main Methods:

  • A retrospective study of 90 children with scorpion sting envenomation over 4.5 years.
  • Prazosin administered at 30 μg/kg/dose, with repeat doses every 6 hours.
  • Severity grading based on local/systemic involvement; acute pulmonary edema managed per standard protocol.

Main Results:

  • Common symptoms included perspiration and cold extremities; shock, myocarditis, encephalopathy, pulmonary edema, and priapism were frequent.
  • Mortality rate was 8.9%. Delayed presentation (after 6 hours) significantly increased mortality.
  • Metabolic acidosis, tachypnea, myocarditis, acute pulmonary edema, encephalopathy, and priapism were associated with higher mortality.

Conclusions:

  • Delayed presentation (over 6 hours) is a critical factor in pediatric scorpion sting outcomes.
  • Metabolic acidosis, tachypnea, myocarditis, acute pulmonary edema, and encephalopathy are significant predictors of mortality in children.
Abstract

Related Concept Videos

Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...